Abstract
Silk fibroin hydrogels occupy an essential position in the biomedical field due to their remarkable biological properties, excellent mechanical properties, flexible processing properties, as well as abundant sources and low cost. Herein, we introduce the unique structures and physicochemical characteristics of silk fibroin, including mechanical properties, biocompatibility, and biodegradability. Then, various preparation strategies of silk fibroin hydrogels are summarized, which can be divided into physical cross‐linking and chemical cross‐linking. Emphatically, the applications of silk fibroin hydrogel biomaterials in various biomedical fields, including tissue engineering, drug delivery, and wearable sensors, are systematically summarized. At last, the challenges and future prospects of silk fibroin hydrogels in biomedical applications are discussed.
Keywords: drug delivery, hydrogel, silk fibroin, tissue engineering, wearable sensors
Benefiting from the remarkable biological and physicochemical properties, silk fibroin hydrogels occupy a vital position in the biomedical field. We review the recent developments of silk fibroin‐derived hydrogels, outline their unique structures and important properties, and highlight their applications in various biomedical fields, including tissue engineering, drug delivery, and wearable sensors.
1.
Key points.
The remarkable physiochemical and biological properties of silk fibroin hydrogels are introduced.
The various preparation strategies of silk fibroin‐derived hydrogels are comprehensively summarized.
The applications of silk fibroin‐derived hydrogels in multifarious biomedical fields are emphasized.
2. INTRODUCTION
Hydrogels are typical water molecule‐rich polymers with three‐dimensional (3D) and cross‐linked network structures. 1 , 2 , 3 Such a network system possesses the ability to absorb a large number of water molecules and swell while maintaining a certain shape in a liquid environment for a long time. 4 , 5 With a porous structure resembling the extracellular matrix (ECM), hydrogels allow the circulation and exchange of nutrients and wastes, thus indicating positive implications for cell adhesion, proliferation, migration, as well as delivery of small or macro‐biomolecules. 6 , 7 , 8 Of note, through the design of the polymer chain structure and the introduction of additives, various excellent properties such as high mechanical strength, suitable degradation rate, and stimuli responsiveness can be imparted to the hydrogels. Therefore, hydrogels show unparalleled application potential in multifarious fields, such as cell culture, tissue engineering, drug delivery, and other fields. Compared with synthetic polymer hydrogels, natural polymer hydrogels (such as collagen, alginate, chitosan, and cellulose) possess unique natural properties similar to tissue structures and satisfactory biocompatibility, thus receiving extensive attention in biomedicine, especially tissue engineering. 9 , 10 , 11 , 12 Although with promising applied results, these polymer hydrogels still show some drawbacks such as poor mechanical performances and high cost.
Silk with abundant output and remarkable mechanical properties has been utilized for thousands of years, and Bombyx mori silkworms are deemed as the world's leading producer. 13 , 14 , 15 , 16 , 17 , 18 Raw silk comprises two parallel silk fibroin fibers with sericin glued to their surface. By degumming raw silk (removing sericin), the obtained silk fibroin as the natural green protein material exhibits excellent biocompatibility, biodegradability, non‐toxicity, thermal stability, together with attractive mechanical strength and toughness, which outperforms many natural and synthetic fibers, playing a pivotal role in the biomedical field. 14 Silk fibroin hydrogels can be manufactured by treating the dissolved degummed fibers with various physical or chemical means. The resultant silk fibroin hydrogels demonstrate positive interactions with biological systems and advantageous performances for cell activities. Particularly, the controllable molecular structures impart tunable mechanical properties and degradation rates to silk fibroin hydrogels, which enables them to adapt to various biological applications flexibly. 13 , 19 Furthermore, there is growing interest in introducing more functions to silk fibroin hydrogels while retaining their inherent properties. Silk fibroin hydrogels, together with their derived composite hydrogels, are endowed with improved mechanical strength, high elasticity, injectability, and environmental sensitivity, resulting in a series of satisfactory research results.
Herein, we summarize the recent research progress of silk fibroin hydrogels in the biomedical field. First, silk fibroin's structures and physicochemical properties are outlined. Then, classified according to the cross‐linking mechanisms, two different gelation methods of silk fibroin hydrogels are introduced. We highlight the current application status of silk fibroin hydrogels for tissue engineering, drug delivery, and as biosensors. Finally, we propose the challenges and development prospects of silk fibroin hydrogels in the biomedical field.
3. STRUCTURES AND PROPERTIES OF SILK FIBROIN
3.1. Structures
Silk fibroin contains a heavy (H‐) chain peptide (390 kDa) and a light (L‐) chain peptide (26 kDa) in a ratio of 1:1, wherein the L‐chain is linked to the C‐terminus of the H‐chain through a single disulfide. 20 Further, the H‐L complex connects with the glycoprotein (P25, 25 kDa) by six to one through the hydrophobic interactions to form a micellar unit. 21 Notably, the formation of ß‐sheet crystallites, the fundamental structural components of silk fibroin, is related to H‐chains. H‐chains consist of 18 types of amino acids, that is, glycine (G, ∼45%), alanine (A, ∼30%), serine (S, ∼12%), tyrosine (Y, ∼5%), valine (V, ∼2%), and other 13 amino acids. 16 Structurally, H‐chains comprise 12 hydrophobic repetitive domains interspersed with 11 hydrophilic non‐repetitive domains (Figure 1A). The hydrophobic domains containing glycine, alanine, and serine can self‐assemble into ß‐crystallites through intermolecular and/or intramolecular interactions. 15 In detail, each repetitive domain comprises about five subdomains partitioned by tetrapeptides (GAAS), while each subdomain comprises diverse repetitive units of hexapeptides (GAGAGX, where X could represent alanine, serine, tyrosine, or valine) and terminates with a tetrapeptide (Figure 1B). 22 The n hydrophilic domains consist primarily of charged or acidic amino acids assembled into the random coils and helical structures in natural silk fiber. 23
3.2. Mechanical properties
Silk fibroin exhibits remarkable mechanical properties over other biomaterials due to its unique hierarchical structures, which are mainly determined by ß‐sheet crystallites. Native silk fibers have been reported to have a large breaking strain (10%–30%), strength (600 MPa), as well as toughness (70 MJ m−3), which are higher than many synthetic fibers. 24 , 25 , 26 Benefiting from the outstanding strength and toughness, an increasing number of researchers have exploited silk fibroin as tissue engineering scaffold materials. 27 , 28 However, it should be noted that in most tissue engineering applications, silk fibroin‐derived scaffolds are usually processed from recombinant fibroin solution, and the resultant scaffolds show weak and brittle performances. Such defects could be ascribed to the chain hydrolysis of fibroin during degumming and dissolution as compared to raw silk fibers, thus leading to a lack of significant secondary and hierarchical structures. 24 , 27 Recently, the mechanical properties of recombinant fibroin have been significantly improved by various processing approaches, such as temperature adjustment, various agents' treatment, and even blended or cross‐linked with other polymer materials. 29 , 30 , 31 , 32
3.3. Biocompatibility
Native silkworm silk fibers have been utilized as sutures in various biomedical applications for decades. 33 , 34 , 35 , 36 Inevitably, the silk fibers show reactions ranging from delayed allergies to acute and chronic inflammatory processes in practical application. 37 Sericin was previously regarded as the main participant in inducing the immune responses mounted against the fibers and ultimately leading to inflammations, such as T‐cell‐mediated anaphylactic reaction. 38 Therefore, braided sutures are often degummed to reduce their inflammatory/immune response for clinical practice. After degumming, silk fibers can be processed into surgical nets, sutures, and clothing for various skin diseases. 33 However, Kaplan et al. have revealed that fibroin and sericin fibers were immunoinert when co‐cultured with macrophages in vitro, while macrophages produced a stronger response when being co‐cultured with sericin‐coated fibroin. 39 Such results suggested that the activation of macrophages was dependent on the physical binding of fibroin and sericin, in which the sericin‐coated fiber might provide improved adhesion for macrophages or the conformation of sericin changed during binding with silk fibroin that stimulates the macrophages. Thus, the use of silk as a biological material requires the separation of these two kinds of proteins to make sericin and silk fibroin independently possess great biocompatibility.
3.4. Biodegradability
Silk fibroin hydrogels have shown excellent in vitro and in vivo degradability. 40 Enzymatic degradation promotes silk fibroin to fragment into smaller polypeptides and eventually become amino acids, so silk fibroin can also be considered bioabsorbable. 41 Many proteolytic enzymes can trigger the degradation of silk fibroin hydrogels, such as protease XIV, proteinase K, α‐chymotrypsin, and papain, etc. 42 , 43 Among them, protease XIV is deemed as the most effective protease so far, which can degrade different silk fibroin‐derived products, including sponges, films, particles, as well as bulk materials, due to its many cleavage sites on silk fibroin chains allowing for more efficient degradation. 43 , 44 Therefore, protease XIV is widely used for the evaluation of in vitro degradation of silk fibroin.
Significantly, the degradation rate of silk fibroin hydrogels is highly dependent on the presence of ß‐sheet structure. 45 It is noted that the native silk fibers show a lower degradation rate than regenerated silk fibroin fibers, which is ascribed to the higher content of ß‐sheet secondary structure of natural silk fibers than that of RSF structure. Lu et al. proposed that the hydrophilic bulk of silk fibroin was first degraded during the degradation process, and then the hydrophobic crystallites got rid of the surrounding and binding of the hydrophilic bulk to become free particles, followed by the movement toward the protease solution. 46 Based on this degradation mechanism, the degradation process of silk fibroin is more controllable and flexible, making it a feasible solution to control the degradation rate of silk fibroin without sacrificing other excellent properties, which extensively expands the application of silk fibroin materials in biomedicine. In addition, silk fibroin's in vivo degradation behavior is related to the body's immune response, in which foreign body giant cells and macrophages perform a critical role in the degradation. Kaplan's team et al. revealed that 8 weeks after SF porous scaffolds were implanted in nude mice and Lewis rats, Lewis rats showed obvious signs of macrophage‐mediated degradation and lost structural integrity compared with nude mice. 47
4. GELATION OF SILK FIBROIN HYDROGEL
Recently, increasing silk fibroin‐derived hydrogel products have emerged for various biomedical applications. According to the cross‐linking method, they could be classified into physically and chemically cross‐linked hydrogels (Figure 2 and Table 1).
TABLE 1.
Classification | Methods | Advantages | Disadvantages | Ref |
---|---|---|---|---|
Physical cross‐linking | Temperature |
|
Slow gelation | 48 , 49 , 51 , 52 |
Shear forces |
|
Relatively high gelation concentration | 53 , 54 , 55 | |
Ultrasound |
|
High ultrasonic intensity | 56 , 57 , 58 , 59 | |
Polar reagents | Rapid and easy processing | Cytotoxicity | 60 , 61 , 62 , 63 | |
pH | Promoted gelation process |
|
48 | |
Carbon dioxide |
|
Slow gelation | 65 , 66 | |
Electric field | Free of residual acids or chemical cross‐linkers |
|
67 , 68 | |
Surfactants | Accelerated gelation | Release of surfactants | 70 , 71 | |
Chemical cross‐linking | Enzymatic cross‐linking |
|
Time‐consuming | 72 , 73 , 74 , 75 |
Chemical agents | Rapid gelation | Cytotoxicity (some agents) | 76 , 77 , 78 , 79 , 80 , 81 , 82 | |
Photo cross‐linking | Efficient, rapid and, mild process | Cytotoxicity | 83 , 84 , 85 , 86 | |
Irradiation | Satisfactory rapidity | High energy consumption | 91 , 92 |
4.1. Physical cross‐linking
Silk fibroin solutions are able to transform into a hydrogel with 3D network structures via physical interactions. 48 Such interactions occur under mild conditions dispensing with chemical cross‐linking agents, whose processing strategies include concentration adjustment, temperature raising, shear force applying, ultrasound trigger, pH change, organic solvent usage, surfactants exposure, salt adding, and electric field applying, etc. 49 , 50
4.1.1. Temperature
For protein‐based materials, temperature is one of the key factors of gel formation. During the temperature‐triggered gelation process, on the one hand, increasing temperature promotes the frequency of effective molecular collisions in the system and then enhances the aggregation of silk fibroin molecules. Besides, the hydrophobic segment of silk fibroin increases with the temperature, thereby strengthening the hydrophobic interactions between molecules. 48 , 50 , 51 Together, these events lead to the aggregation and self‐assembly of silk fibroin. In silk fibroin, the temperature‐trigged transition is irreversible because of the thermodynamically stable property of formed ß‐sheets. Generally, silk fibroin solutions could be stored at 4°C for around a week, while gelation occurs faster by placing solutions at room temperature. 49 , 52
4.1.2. Shear forces
Significantly, silk fibroin exhibits great sensitivity to mechanical forces. 54 Native fibroin solutions experience only subtle tensile and shear flow forces in the silk gland to prevent premature gelation of fibers prior to final spinning. 50 Therefore, applying shear forces to the silk fibroin solutions in vitro can easily promote the ß‐sheet structure formation in silk fibroin hydrogels. 54 Stirring and flowing are both able to induce the conformation transition of silk fibroin from disordered helical structures to ordered ß‐sheet structures. In addition, vortexing is a useful strategy to induce variation in shear gradients of fibroin structures, during which gel dynamics can be manipulated by changing the vortexing time and thus various time‐sensitive applications, such as cell encapsulation, are allowed. 55 These properties lead to faster gelation of silk fibroin, and such a gelation approach is easily operated and requires no toxic reagents, making it an attractive green method.
4.1.3. Ultrasound
Ultrasound can accelerate the intermolecular interactions of silk fibroin and induce its structural changes, thereby promoting rapid gelation. 56 , 57 , 58 The changes caused by ultrasonication include local temperature rise, shear force extension, and gas–liquid interface balance change. 53 Natalia Gorenkova et al. treated silk fibroin solution with ultrasound for 15–45 s to induce its gel formation. 59 Benefiting from the advantages of rapidity, controllability, environmental protection, and nontoxic by‐products, the ultrasonic method is regarded as an effective physical method to prepare silk fibroin hydrogels. In the process of applying this method, the pregel solution concentration, ultrasonic output power, and action time are the principal elements for the resultant hydrogels.
4.1.4. Polar reagents
To accelerate the physical gelation process, alcohols can usually be introduced to induce the ß‐sheet formation in silk fibroin hydrogels. 60 , 61 , 62 , 63 , 64 The polarity of the solvent plays a significant role during the gelation process of silk fibroin using the mechanism that the polar reagents use to capture water molecules from the silk molecular chains, resulting in the formation of ß‐sheet nucleation sites. 53 Notably, different alcohols show diverse induction effects on fibroin gelation. Alcohols containing longer fatty segments, such as n‐butanol, induce ß‐sheet formation in a milder manner. 60 Although with rapid and easy processing, solvents' presence is one of the factors limiting cell applications (especially in situ cell encapsulation).
4.1.5. Others
Adjusting pH value is also a familiar way to induce the gelation of silk fibroin. When the pH of the silk solution reaches its isoelectric point (pH 3.8–4.0), minimal charge repulsion occurs, and the silk fibroin nanoparticles remain on an unstable course, which is more easily aggregating to form a hydrogel. 48 Particularly, adding carbon dioxide into the silk fibroin solution can also adjust the pH. 65 , 66 Besides, it is worth mentioning that applying an electric field can also act as an inducer for fibroin gelation. 67 Under the applied electric field, the movement toward the anode of numerous protons in the solution results in a lower pH compared with the isoelectric point of the silk fibroin. 68 As a result, the silk fibroin molecules show electronegativity so that they aggregate near the anode and finally form a hydrogel network. In addition, various surfactants represented by sodium dodecyl sulfate (SDS) can also be utilized to alter the silk gelation rate. 69 , 70 Adding surfactants can increase the hydrophobic interactions between silk molecules, as well as silk fibroin and surfactants, thus promoting the formation of ß‐sheet structures and accelerating the gelation process. 71
4.2. Chemical cross‐linking
Although the physical cross‐linking method is simple to operate, requires no chemical reagents and has a mild reaction process, the physically cross‐linked hydrogels are often brittle and show poor mechanical properties. In contrast, the chemical cross‐linking method effectively overcomes these limitations, and the performances of derived hydrogels, such as mechanical strength, porosity, swelling degree, together with biodegradability, can be more flexibly tuned.
4.2.1. Enzymatic cross‐linking
Enzymatic cross‐linked hydrogels have attracted considerable interest in biomedical applications owing to their moderate reaction conditions and remarkable biocompatibility. Commonly used enzymes include horseradish peroxidase (HRP), glutaminase, and tyrosinase. 32 , 72 , 73 , 74 Among them, HRP is the most popular enzymatic cross‐linking agent. Adding HRP/hydrogen peroxide (H2O2) to the silk fibroin solution can form a stable, highly elastic, and transparent hydrogel, which is due to the fact that HRP promotes the cross‐linking of tyrosine residues in fibroin molecular chains by forming free radicals in the presence of H2O2. 75 The concentrations of HRP and H2O2 can control the mechanical properties of resultant silk fibroin hydrogels. Compared with physically cross‐linked and other chemical cross‐linking agent‐derived hydrogels, HRP/H2O2 catalyzed cross‐linking to prepare silk fibroin hydrogels shows a series of advantages. One of the significant features is the excellent biocompatibility and tunable biodegradability. In particular, the enzymatic cross‐linking can regulate the fragility of silk fibroin hydrogels while maintaining their elastic structures similar to ECM.
4.2.2. Chemical agents
Chemical cross‐linking agents, such as genipin, glutaraldehyde, epoxide, and carbodiimide, can be covalently combined with the hydroxyl, amino, carboxyl, and other active groups in the silk fibroin molecule chains. 76 Genipin is deemed as an excellent natural cross‐linking agent with lower toxicity than other conventional chemical cross‐linking agents. 77 The cross‐linking reaction between genipin and silk fibroin is mainly related to lysine and arginine. Due to the low proportion of lysine and arginine in the silk fibroin, the genipin‐based cross‐linking process takes a long time. 78 Glutaraldehyde can react with the ε‐amino and phenol group of lysine and tyrosine in fibroin, respectively, and its cross‐linking reaction with silk fibroin molecules has been confirmed. 79 However, the cytotoxicity of glutaraldehyde limits its wide application. As for epoxide, it undergoes chemical cross‐linking reactions with amino acid residues such as lysine, tyrosine, histidine, and arginine on the side chain of silk fibroin. 80 Additionally, 1‐(3‐Dimethylaminopropyl)‐3‐ethylcarbodiimide hydrochloride (EDC) can react with amino acids of silk fibroin with carboxyl side chains such as lysine, glutamic acid, and aspartic acid, so EDC is able to be utilized for the chemical cross‐linking reaction of silk fibroin. 81 In particular, more stable amine‐reactive N‐Hydroxy succinimide (NHS) ester intermediates can be generated when adding NHS into the EDC reaction system, thereby improving the cross‐linking reaction efficiency. 82
4.2.3. Photo cross‐linking
Photo‐cross‐linking is a method that utilizes ultraviolet/visible light to trigger the polymerization process of materials. The first strategy to produce photo‐cross‐linked silk hydrogel is the formation of covalent bonds between reactive photoreactive groups (mainly tyrosine residues) of fibroin with the addition of reductants. Whittaker et al. first proposed a rapid and mild ruthenium (Ru)‐catalyzed photo‐cross‐linking strategy to generate silk fibroin hydrogels. 83 , 84 In fibroin solution, under the catalysis of tris(2,2‐bipyridyl) dichloro ruthenium (II) hexahydrate (Ru(II)(bpy)3 2+), visible light induced the cross‐linking of silk fibroin via di‐tyrosine links to form hydrogels. Similar to Ru, riboflavin‐mediated photo‐cross‐linking is also achieved through the formation of di‐tyrosine bonds. 85 , 86 Besides, the second photo‐cross‐linking strategy is a chemical modification of silk fibroin chains. Methacryloyl allows efficient and rapid free radical polymerization; so methacryloyl modification has become a versatile processing method for the photo‐cross‐linked silk fibroin hydrogel. Recently, glycidyl methacrylate (GMA) has been mainly studied for the introduction of methacryloyl groups to silk fibroin. 87 , 88 , 89 , 90
4.2.4. Irradiation
Irradiation technology has developed an advanced strategy to prepare hydrogels, because the polymer chains can easily undergo chemical cross‐linking and copolymerization under irradiation, and finally hydrogels are obtained. Such a process is controllable and simple, requires no additives such as initiators and cross‐linking agents, and shows satisfactory rapidity and economy. Gamma‐ray (γ‐ray) irradiation induces the generation of amounts of free radicals from polymer chains and water molecules, whose reorganization leads to intermolecular cross‐linking and forming of a hydrogel network. 91 Recently, γ‐ray irradiation has been used to generate the silk fibroin hydrogel. From the research results of Kim et al., the secondary structure of the fibroin hydrogel formed by γ‐ray irradiation showed no change, which was still a random coil conformation, indicating that the hydrogel was formed by chemical cross‐linking reaction. 92
It is worth mentioning that silk fibroin hydrogels can also be prepared by combining physical and chemical cross‐linking strategies. 53 Kim et al. prepared silk fibroin hydrogels using photochemical cross‐linking and methanol‐induced physical cross‐linking. 93 The pregel solution was exposed to visible light for 60 s to gel and then treated with 90% (v/v) methanol for 60 min. The resultant silk hydrogel showed high elasticity as well as outstanding structural stability. In another study, Su et al. reported a dual cross‐linked hydrogel by HRP/H2O2 pre‐cross‐linking and followed ethanol‐induced physical cross‐linking. 94 Likewise, the resulting dual cross‐linked hydrogels were demonstrated to have enhanced mechanical properties and significantly increased stability. The aforementioned dual cross‐linked hydrogels consist of only a single silk fibroin network, wherein both chemical and physical cross‐links are present. In addition, double‐network hydrogels in which other material‐based hydrogel networks are introduced have also been proposed. Xiao and colleagues used ultrasonic and photopolymerization strategies to construct a double‐network hydrogel based on silk fibroin and methacrylated hyaluronic acid, showing high mechanical strength, high water content, and slow degradation rate. 95
5. SILK FIBROIN HYDROGELS FOR TISSUE REGENERATION
Over the past decades, silk fibroin hydrogels have shown significant potential in multifarious tissue engineering applications, involving bone, cartilage, skin, nerve, vascular, ligament, tendon, liver, cornea, eardrum, dental, bladder, etc. 96 In this chapter, we will focus on the applications of silk fibroin hydrogel on bone, cartilage, skin, and nerve regeneration applications.
5.1. Skin regeneration
As the largest organ of the human body, the skin is composed of the epidermis and dermis tightly combined and is the body's barrier against infectious microorganisms. Severe damage to the skin can result in loss of skin integrity, disability, and even death in severe cases. Silk fibroin hydrogels have been shown to support the attachment and migration of fibroblasts and keratinocytes and have been widely used for skin regeneration. 97 Jing's group reported a hybrid hydrogel containing silk fibroin and tannic acid (SF‐TA) with remarkable antibacterial and antioxidant activity, which contributed to the accelerated wound healing of mice with full‐thickness skin defects (Figure 3A). 98 Similarly, mixing silk fibroin with carboxymethyl chitosan (CMCS) can also yield hydrogel dressings with antibacterial properties. Silk fibroin/CMCS hydrogel sustained a proper microenvironment for wound healing and promoted re‐epithelialization and granulation tissue formation (Figure 3B). 99 The development of biomaterials that can mimic the natural cellular environment in structure and function is also a primary objective of tissue engineering. In a recent study, a novel bioactive hydrogel comprising self‐assembling peptides and silk fibroin was designed for skin tissue engineering. Amphiphilic peptide could trigger rapid gelation of silk fibroin through cooperative self‐assembly and confer hydrogel ability to promote the adhesion, growth, and migration of endothelial cells. When implanted into a defected area, such a hydrogel could promote angiogenesis and epidermization, thereby achieving epidermal repair (Figure 3C). 100 Furthermore, depending on the type of wound, functionalizing the hydrogel dressing with various signaling molecules or factors is another fascinating alternative. For example, the asiaticoside (AC) was loaded into silk fibroin nanofiber hydrogels to regulate inflammatory responses and angiogenesis, achieving scar‐free skin regeneration after implantation into full‐thickness wound defects. 101 Furthermore, silver nanoparticles with antibacterial properties and glycyrrhizic acid (GA) with anti‐inflammatory properties were also introduced into the silk fibroin hydrogel matrix to generate a dressing for wound healing. 102
5.2. Bone regeneration
Bone, as a special connective tissue, is mainly composed of type I collagen and hydroxyapatite, the nanocomposite structure of which contributes to the strength and hierarchical structure of bone tissue. 103 Benefiting from their high toughness, robust mechanical strength, excellent biocompatibility, and slow biodegradability, silk fibroin hydrogel‐derived bone tissue engineering scaffolds have been developed as a very popular choice. Meinel et al. reported that porous silk fibroin‐based scaffolds precultured in a bioreactor for 5 weeks were implanted into defects of the mouse skull and successfully induced bone formation within 5 weeks. 104 In addition, silk fibroin hydrogels can be combined with other biomaterials and therapeutic agents to enhance osteogenic properties. 105 , 106 , 107 , 108 , 109 Jiang and coworkers presented silk fibroin/gelatin hydrogels with controllable strength and degradation rate, together with good biocompatibility and the capability to promote the proliferation and differentiation of BMSCs (Figure 4A). 110 It was demonstrated that 12 weeks after being implanted into the skull defect, the silk fibroin/gelatin hybrid hydrogel could improve the bone regeneration quality and enhance the bone regeneration rate with less tissue response. In another study, Kim et al. used γ‐ray irradiation to fabricate hydroxyapatite nanoparticle (HAP NP)‐containing silk fibroin hydrogels for bone regeneration. They verified that the resultant silk fibroin/HAP NP composite hydrogel promoted osteogenic differentiation compared with pure silk fibroin hydrogels. 91 It is important to note that thorough and fast vascularization is necessary to improve bone regeneration efficiency. Zhang and colleagues proposed an in situ formed silk hydrogel encapsulated with bone morphogenetic protein‐2 (BMP‐2) and vascular endothelial growth factor (VEGF165), aiming to promote new bone formation and angiogenesis (Figure 4B). 111 These two elements showed synergistic effects on new bone formation, while an injectable silk hydrogel matrix was applied in a minimally invasive way to fill irregular bone defects.
5.3. Cartilage regeneration
Cartilage is a supportive avascular connective tissue composed of chondrocytes and intercellular substances. Severe joint trauma, biomechanical imbalances, and degenerative changes can cause cartilage damage. Due to the limited self‐repairing ability of cartilage, these injuries often result in progressive damage and degeneration. Using the appropriate biomaterials as tissue engineering scaffolds is emerging as a potential alternative clinical strategy for cartilage repair. Among the numerous biomaterials used for osteochondral tissue engineering, silk fibroin hydrogels have attracted much attention owing to their outstanding physicochemical and biological performances. Researchers found that the silk fibroin hydrogel‐derived constructs showed functional properties matched with agarose‐based engineered cartilage. 112 Subsequently, microfiber silk and ultrasound‐induced silk fibroin hydrogel were combined to develop a mechanically enhanced hydrogel for cartilage tissue engineering, which was observed with satisfactory chondrocyte response (Figure 5A). 113 In particular, combining functional agents helps to improve the cartilage repair effect. Shen et al. used injectable silk fibroin hydrogels containing chondrocytes and exosomes to repair cartilage defects, effectively promoting cartilage regeneration in vivo. 107 Zhang et al. proposed a multifunctional hydrogel composed of silk fibroin/TA for relieving oxidative stress and enhancing osteochondral regeneration, and bone marrow mesenchymal stem cells (BMSCs)‐specific affinity peptides were incorporated into hydrogels to recruit endogenous BMSCs (Figure 5B). 114 As engineering technology develops, 3D printing technology has inspired a new wave of tissue engineering. 115 , 116 , 117 Lee and workers constructed intact ear cartilage using silk fibroin and polyvinyl alcohol (PVA) composite hydrogels. 118 The glycidyl methacrylate‐modified silk fibroin hydrogel prepared by Hong et al. based on 3D printing technology promoted the viability, proliferation, and differentiation into the cartilage of encapsulated cells for up to 4 weeks (Figure 5C). 28 In the study by Li et al., 3D‐printed silk fibroin and gelatin hydrogel scaffolds were proposed, and enzymatic cross‐linking and methanol‐treated hybrid hydrogels combined with encapsulated cells could promote articular cartilage regeneration after 12 and 16 weeks of implantation. 119
5.4. Nerve regeneration
The human nervous system can fall into the central nervous system (CNS) and peripheral nervous system (PNS). PNS with minor injuries shows self‐repairing capability, while larger peripheral nerve injuries require autologous transplantation. In contrast, the repair of CNS injury is a complicated process due to endogenous factors inhibiting repair. Therefore, bioengineering approaches for PNS focus on replacements for nerve grafts, while solutions for CNS repair focus on creating a suitable environment to allow nerve regeneration. Silk fibroin hydrogels have been used to repair peripheral and central nerve injuries. Our recent work presented a novel silk fibroin hydrogel nerve conduit with great biocompatibility and suitable biodegradability, enabling targeted delivery of nerve growth factor (NGF) and efficient nerve repair (Figure 6A). 120 Zhou et al. synthesized basic fibroblast growth factor (bFGF)‐loaded methacrylate‐silk fibroin hydrogels, which promoted neurite regeneration, inhibited glial cell proliferation, and improved neuronal mitochondrial function (Figure 6B). 121 Furthermore, conductive hydrogels have emerged for nerve tissue regeneration due to their ability to mimic the biochemical and biophysical cues of the natural ECM, thereby enhancing the function of Schwann cells (SCs) and neurons. 122 Zhao et al. fabricated the conductive biocomposite hydrogels containing silk and graphene oxide (GO) nanosheets. It was proved that the soft matrix contributed to SC survival and proliferation, while the increased conductivity favored the functional behavior of SCs. 123 Importantly, topological microstructure design is also the focus of the nerve regeneration scaffolds. Gu et al. reported a pure silk fibroin hydrogel with a high‐strength and arrayed microgroove topography, showing a strong ability to promote directional outgrowth of axons and guide axonal sprouting. 124 Tang et al. developed a silk‐based light‐triggered gel system with anisotropic topography and adhesion ligands, which achieved enhanced cell recruitment and myelination (Figure 6C). 125 Besides, silk nanofiber hydrogels with aligned microstructures and NGF loaded provided dual physical and biological cues for promoting spinal cord regeneration (Figure 7A). 126 More interestingly, Lin et al. fabricated a smart silk fibroin/gelatin hydrogel scaffold integrating topographic, biological, and synergistic effects of electrical stimulation to enhance neuronal activity. Such a multifunctional hydrogel device offered a predictable opportunity to develop novel nerve grafts (Figure 7B). 127
6. SILK FIBROIN HYDROGELS FOR DRUG DELIVERY
In the aspect of drug delivery, silk fibroin hydrogels are widely employed as drug delivery carriers due to their self‐assembly, processing flexibility, biocompatibility, biodegradability, as well as abilities to capture, retain, protect, and deliver therapeutic payloads. 19 , 128 , 129 , 130 , 131 Zhang et al. presented an in situ formed silk fibroin hydrogel as a carrier to encapsulate bifactors. In vitro experiments presented that both of the loaded two factors showed no obviously explosive release, while in vivo tests proved an additive effect of VEGF165 and BMP‐2 released from the silk hydrogel on promoting angiogenesis and bone regeneration (Figure 8A). 111 Sustained and slow delivery of the therapeutic payloads contributes to reducing the dosing frequency in clinical patients, thereby increasing their compliance. 132 The processing parameters of silk fibroin hydrogels, such as the silk number, influence the silk vehicle performance. By reducing the content of silk fiber to 1% (wt), the drug release could be increased by a factor of 4.5 compared to the 6% (wt) hydrogel, which was attributed to the increased adsorption behavior of doxorubicin (DOX) on the silk hydrogel network structure with increasing ß‐sheet content in the hydrogel. This result indicated the controllable drug release behavior influenced by the silk content. 133 In addition, the deferoxamine (DFO)‐loaded silk nanofiber hydrogels proposed by Kaplan's group achieved a sustained release of DFO over 40 days, which improved skin tissue repair by stimulating the formation of the vascular network (Figure 8B). 134 , 135 Besides, the modification of silk hydrogels shows an impact on their overall performance. 136 , 137 Atterberry et al. prepared hydrogels with ordinary silk fibroin and sulfonic acid‐modified silk fibroin. 138 Compared with plain silk hydrogels, the modified hydrogels showed minimal burst and sustained release, which might be ascribed to the electrostatic interactions and hydrophobic effects (Figure 8C). Furthermore, many strategies have also been reported to improve the performance and drug delivery capacity of silk fibroin‐based hydrogels. For example, some other polymers or functional elements were involved in improving the physicochemical properties of silk fibroin hydrogels, or the drug‐loaded nanoparticles were introduced to further delay drug release (Figure 8D). 133 , 139 , 140 , 141 , 142 Notably, microneedle (MN) technology provides a promising approach for drug delivery using noninvasive percutaneous treatment. 143 , 144 , 145 Chen et al. reported a glucose‐responsive MN composed of silk fibroin and phenylboronic acid/acrylamide for smart insulin delivery (Figure 8E). 146 The prepared MNs autonomously released insulin adapted to the glucose level changes.
Hitherto, Zhao's group has conducted numerous studies on the construction of drug delivery vehicles based on silk fibroin hydrogels. In 2019, we firstly reported silk fibroin hydrogel microspheres with inverse opal structures for drug delivery and postoperative treatment of tumors. 147 On this basis, we combined the temperature‐responsive hydrogel (poly (N‐isopropylacrylamide), PNIPAM) with silk fibroin inverse opal microcarriers, achieving the controllable and sustained release of loaded drugs from carriers. 148 Later, the introduction of functional elements, black phosphorus quantum dots, endowed silk fibroin inverse opal microspheres with photoresponsivity, while the secondary filling of gelatin with reversible phase transition capability enabled the sustained release of loaded drugs. 149 The composite silk fibroin microcarriers have been demonstrated with the controlled drug delivery ability triggered by near‐infrared light, showing gratifying effect in wound repair. In addition to microspheres, we integrated inverse opal structures with tubular scaffolds to construct nerve conduits with localized delivery of growth factors, and in vitro and in vivo experiments confirmed their long‐term drug delivery ability. 120 Overall, the silk fibroin hydrogels loaded with various therapeutic agents in different forms have shown positive outcomes on sustained, controllable, targeted, safe, and efficient delivery. We believe these works will provide new ideas for constructing silk fibroin‐based hydrogel delivery systems.
7. SILK FIBROIN HYDROGELS AS WEARABLE SENSORS
Wearable electronic devices have shown broad application potential in movement monitoring, personal medical and health care, as well as food hygiene and safety inspection, attracting people and increasing attention in recent years. 150 , 151 Wearable sensors are one of the key elements of flexible wearable electronic devices. With the rapid development of biomaterials and manufacturing processes, silk fibroin has become a promising substrate or sensing element for wearable sensor applications due to its remarkable biocompatibility, degradability, ease of processing, together with brilliant mechanical properties. Silk fibroin hydrogel‐based wearable sensors include mechanical (strain and pressure) sensors, humidity sensors, temperature sensors, electrophysiological sensors, and so on. 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 In a 2021 study, He et al. prepared a composite silk fibroin hydrogel strain/pressure sensor by mixing with polyacrylamide, graphene oxide, and poly(3,4ethylenedioxythiophene): poly(styrenesulfonate) (PEDOT: PSS) in proportions, which showed a wide sensing rage with 2%–600% strain and 0.5–119.4 kPa pressure (Figure 9A). 162 Such a composite silk fibroin hydrogel sensor has been confirmed to monitor different human body signals. Through using silk fibroin, PVA, borax, and TA, Zheng et al. designed an ionically conductive hydrogel sensor, which can monitor changes of large strain movements, such as bending of finger joins and wrists, and could be utilized for sensitive and quick detection of micro‐deformation behaviors such as smiling, frowning, and breathing (Figure 9B). 156 Uniquely, a type of mechanical sensor presented by Zhang et al. could not only detect variation in mechanical signals but also be integrated with drug‐loaded silk microneedles, showing satisfactory effects in continuous monitoring and treatment of epilepsy (Figure 9C). 163 Remarkably, in our recent work, we combined silk fibroin hydrogels with inverse opal scaffolds to construct a composite hydrogel showing bright structural color and good electrical conductivity, stretchability, and flexibility (Figure 9D). 164 The prepared hydrogel exhibited distinct structural color changes and resistance variation during the bending process, enabling it to be a visually wearable sensor with real‐time color sensing and electrical signal reporting capabilities.
In addition to the mechanical response, the real‐time feedback to the temperature variation of the body and surrounding environment is another vital ability of sensors. 165 , 166 Chen et al. embedded silver nanowires on the surface of silk fibroin hydrogels to prepare a pressure/temperature dual‐responsive sensor with excellent performances (Figure 10A). 165 The temperature response test showed the high sensitivity and durability of the sensor from −30 to 50°C. In another report, Seo et al. proposed a calcium (Ca2+)‐modified silk fibroin hydrogel‐derived biosensor for electrophysiological signal monitoring (Figure 10B). 167 Due to the incorporation of Ca2+, the mechanical interlocking of the interface between the silk fibroin hydrogel and the biological surface was enhanced, resulting in the robust adhesive property. Besides, its stretchability, electrical conductivity and reusability have also been confirmed. These properties make the resultant silk hydrogel useful as a multifunctional sensor. Particularly, the electrocardiogram (ECG) signals measured with silk fibroin adhesive were not distorted even while undergoing repeated bending and maintained comfortable contact with the skin, and thus ECG signals could be continuously and accurately recorded. In contrast, metal electrodes using commercial hydrogels (with lower peel strength) exhibited fluctuations in the measured signal during the bending process. In a recent study, Wahab et al. proposed a type of photoresponsive, self‐healing, and conductive optoelectronic (OE) skin using silk fibroin hydrogel and melanin nanoparticles (Figure 10C). 168 Melanin nanoparticles with special photosensitive conductivity were incorporated into silk fibroin hydrogels and exhibited enhanced conductivity triggered by light irradiation. Such a novel OE skin showed humidity‐dependent conductivity, making it possible as a humidity sensor. In addition, illuminating the hydrogel region with a 532 nm green laser produced a higher current, which could be captured so the laser irradiation path could be derived to read out the encoded signal. Interestingly, OE skin could also be used as body‐integrated ultraviolet sensors to detect harmful ultraviolet rays, as the photocurrent ratio increased with the irradiated power density.
8. CHALLENGES AND PROSPECTS
Silk fibroin hydrogels possess excellent biocompatibility, tunable mechanical properties and degradation rates, thermal stability, and easy chemical modification, all of which make them extremely promising in biomedical fields. With the continuous deepening of researches on silk fibroin, the research process of new products based on silk fibroin hydrogel has been greatly accelerated. However, there are still some key issues that need to be explored in depth.
First, pure silk fibroin hydrogels have shown poor ability to attach and proliferate certain cells, and 3D cell cultivation has been limited. Therefore, a more comprehensive view of the relationship between silk fibroin hydrogels and various cells and tissues is required. Researchers need to consider combining silk fibroin with bioactive peptides or other ECM components, or modifying silk fibroin to enhance its applicability in biological applications. Various physical and chemical cross‐linking strategies have been outlined, but it is necessary to fully consider the influence of different gelation strategies on the viability of encapsulated cells and to optimize suitable processing tactics. In addition, the latest engineering manufacturing technologies, such as 3D printing, nanotechnology, genetic engineering, and even 4D printing technology, should be focused on exploring new silk fibroin hydrogel‐based biomaterials, aiming to meet specific needs in different situations. By regulating the secondary structure of silk fibroin, its mechanical performance and degradation rate can be optimized. For tissue engineering, it is especially necessary to design secondary silk structures so that the mechanical properties and degradation rate can match the new tissues. Most importantly, the current researches on silk fibroin hydrogels focus on cell and small animal models instead of large animal models, resulting in the slow clinical translation process. Therefore, more research studies are needed to develop products based on this excellent biomaterial, leading to clinical trials and FDA approval.
AUTHOR CONTRIBUTIONS
Renjie Chai, Minli Li and Yong Zhang provided the idea; Hui Zhang, Dongyu Xu, Renjie Chai, Minli Li and Yong Zhang wrote and revised the manuscript.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ACKNOWLEDGEMENTS
This work was supported by grants from National Key R&D Program of China (2021YFA1101300, 2020YFA0112503), Strategic Priority Research Program of the Chinese Academy of Science (XDA16010303), National Natural Science Foundation of China (Nos. 82030029, 81970882, 92149304), Natural Science Foundation from Jiangsu Province (No. BE2019711), Science and Technology Department of Sichuan Province (No. 2021YFS0371), Shenzhen Fundamental Research Program (JCYJ20190814093401920, JCYJ20210324125608022), and Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University (No. SKLGE‐2104), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX21_0081).
Biographies
Hui Zhang received her BS degree from the School of Biological Science and Medical Engineering of Southeast University in 2019. She is now a Ph.D. candidate at the School of Life Science and Technology of Southeast University. Her current scientific interests are focused on drug delivery, tissue engineering and biomaterials.
Yong Zhang is currently an associate professor at the School of Physics of Southeast University. His current scientific interests are focused on the kinetics of adsorption and transport of DNA in micro‐nanofluidic devices, as well as the multi‐scale simulation of soft matter molecules in interfaces and complex fluids.
Minli Li is an associate professor at the School of Biological Science and Medical Engineering of Southeast University. She received her Ph.D. degree from the School of Biological Science and Medical Engineering of Southeast University in 2010. Her current scientific interests include genomic studies of mammals and marine invertebrates, biomaterials, and tissue engineering.
Renjie Chai is a full professor at the School of Life Science and Technology of Southeast University. He received his Ph.D. degree from Baylor University in 2009 and worked as a postdoctoral fellow at Stanford University from 2009 to 2013. He has long been committed to the regeneration and protection of neurons and inner ear hair cells, as well as the transcriptional regulation mechanism of neural stem cells and inner ear stem cells.
Zhang H., Xu D., Zhang Y., Li M., Chai R., Smart Med. 2022, 1(1), e20220011. 10.1002/SMMD.20220011
Contributor Information
Yong Zhang, Email: zyfghe@seu.edu.cn.
Minli Li, Email: lml@seu.edu.cn.
Renjie Chai, Email: renjiec@seu.edu.cn.
REFERENCES
- 1. Correa S., Grosskopf A. K., Lopez Hernandez H., Chan D., Yu A. C., Stapleton L. M., Appel E. A., Chem. Rev. 2021, 121, 11385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Zhang Y. S., Khademhosseini A., Science 2017, 356, eaaf3627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Yuk H., Lu B., Zhao X., Chem. Soc. Rev. 2019, 48, 1642. [DOI] [PubMed] [Google Scholar]
- 4. Lin C., Metters A. T., Adv. Drug Deliv. Rev. 2006, 58, 1379. [DOI] [PubMed] [Google Scholar]
- 5. Caccavo D., Cascone S., Lamberti G., Barba A. A., Chem. Soc. Rev. 2018, 47, 2357. [DOI] [PubMed] [Google Scholar]
- 6. Zhu Y., Zhang Q., Shi X., Han D., Adv. Mater. 2019, 31, 1804950. [DOI] [PubMed] [Google Scholar]
- 7. Chimene D., Kaunas R., Gaharwar A. K., Adv. Mater. 2020, 32, 1902026. [DOI] [PubMed] [Google Scholar]
- 8. Daly A. C., Riley L., Segura T., Burdick J. A., Nat. Rev. Mater. 2020, 5, 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Dimatteo R., Darling N. J., Segura T., Adv. Drug Deliv. Rev. 2018, 127, 167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Wang J., Shao C., Wang Y., Sun L., Zhao Y., Engineering 2020, 6, 1244. [Google Scholar]
- 11. Shao C., Liu Y., Chi J., Ye F., Zhao Y., Engineering 2021, 7, 1778. [Google Scholar]
- 12. Catoira M. C., Fusaro L., Di Francesco D., Ramella M., Boccafoschi F., J. Mater. Sci. Mater. Med. 2019, 30, 115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Liu J., Ge X., Liu L., Xu W., Shao R., Mater. Adv. 2022, 3, 2291. [Google Scholar]
- 14. Koh L. D., Cheng Y., Teng C., Khin Y. W., Loh X. J., Tee S. Y., Low M., Ye E., Yu H., Zhang Y., M. Han , Prog. Polym. Sci. 2015, 46, 86. [Google Scholar]
- 15. Wang C., Xia K., Zhang Y., Kaplan D. L., Acc. Chem. Res. 2019, 52, 2916. [DOI] [PubMed] [Google Scholar]
- 16. Huang W., Ling S., Li C., Omenetto F. G., Kaplan D. L., Chem. Soc. Rev. 2018, 47, 6486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hardy J. G., Scheibel T. R., Prog. Polym. Sci. 2010, 35, 1093. [Google Scholar]
- 18. Bai S., Liu S., Zhang C., Xu W., Lu Q., Han H., Kaplan D. L., Zhu H., Acta Biomater. 2013, 9, 7806. [DOI] [PubMed] [Google Scholar]
- 19. Zhang S., Shah S. A. M., Basharat K., Qamar S. A., Raza A., Mohamed A., Bilal M., Iqbal H. M. N., J. Drug Deliv. Sci. Technol. 2022, 72, 103385. [Google Scholar]
- 20. Zhou C., Confalonieri F., Medina N., Zivanovic Y., Esnault C., Yang T., Jacquet M., Janin J., Duguet M., Perasso R., Li Z., Nucleic Acids Res. 2000, 28, 2413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Inoue S., Tanaka K., Arisaka F., Kimura S., Ohtomo K., Mizuno S., J. Biol. Chem. 2000, 275, 40517. [DOI] [PubMed] [Google Scholar]
- 22. Zhou C., Confalonieri F., Jacquet M., Perasso R., Li Z., Janin J., PROTEINS: Struct. Funct. Genet. 2001, 44, 119. [DOI] [PubMed] [Google Scholar]
- 23. Liu H., Sun Z., Guo C., Adv. Fiber Mater. 2022, 4, 705. [Google Scholar]
- 24. Sun W., Gregory D. A., Tomeh M. A., Zhao X., Int. J. Mol. Sci. 2021, 22, 1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Gosline J. M., Guerette P. A., Optlepp C. S., Savage K. N., J. Exp. Biol. 1999, 202, 3295. [DOI] [PubMed] [Google Scholar]
- 26. Blamires S. J., Spicer P. T., Flanagan P. J., Front. Mater. 2020, 7, 29. [Google Scholar]
- 27. Kundu B., Rajkhowa R., Kundu S. C., Wang X., Adv. Drug Deliv. Rev. 2013, 65, 457. [DOI] [PubMed] [Google Scholar]
- 28. Hong H., Seo Y. B., Kim D. Y., Lee J. S., Lee Y. J., Lee H., Ajiteru O., Sultan M. T., Lee O. J., Kim S. H., Park C. H., Biomaterials 2020, 232, 119679. [DOI] [PubMed] [Google Scholar]
- 29. Tan X., Liu L., Mitryashkin A., Wang Y., Goh J. C. H., ACS Biomater. Sci. Eng. 2022, 8, 3242. [DOI] [PubMed] [Google Scholar]
- 30. Guan Y., You H., Cai J., Zhang Q., Yan S., You R., Carbohydr. Polym. 2020, 239, 116232. [DOI] [PubMed] [Google Scholar]
- 31. Shi W., Sun M., Hu X., Ren B., Cheng J., Li C., Duan X., Fu X., Zhang J., Chen H., Ao Y., Adv. Mater. 2017, 29, 1701089. [DOI] [PubMed] [Google Scholar]
- 32. Hasturk O., Jordan K. E., Choi J., Kaplan D. L., Biomaterials 2020, 232, 119720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Holland C., Numata K., Rnjak‐Kovacina J., Seib F. P., Adv. Healthc. Mater. 2019, 8, 1800465. [DOI] [PubMed] [Google Scholar]
- 34. Sivanesan N., Venugopal R., Subramanian A., J. Ind. Tex. 2021, 51, 5202S. [Google Scholar]
- 35. Wang X., Liu P., Wu Q., Zheng Z., Xie M., Chen G., Yu J., Wang X., Li G., Kaplan D., ACS Appl. Mater. Interf. 2022, 14, 11177. [DOI] [PubMed] [Google Scholar]
- 36. Yang Y., Chen X., Ding F., Zhang P., Liu J., Gu X., Biomaterials 2007, 28, 1643. [DOI] [PubMed] [Google Scholar]
- 37. Kundu B., Kurland N. E., Bano S., Patra C., Engel F. B., Yadavalli V. K., Kundu S. C., Prog. Polym. Sci. 2014, 39, 251. [Google Scholar]
- 38. Fu Z., Li W., Wei J., Yao K., Wang Y., Yang P., Li G., Yang Y., Zhang L., ACS Biomater. Sci. Eng. 2022, 8, 1494. [DOI] [PubMed] [Google Scholar]
- 39. Panilaitis B., Altman G. H., Chen J., Jin H. J., Karageorgiou V., Kaplan D. L., Biomaterials 2003, 24, 3079. [DOI] [PubMed] [Google Scholar]
- 40. Liu B., Song Y., Jin L., Wang Z., Pu D., Lin S., Zhou C., You H., Ma Y., Li J., Yang L., Sung K. L., Zhang Y., Colloids Surf. B Biointerfaces 2015, 131, 122. [DOI] [PubMed] [Google Scholar]
- 41. Cao Y., Wang B., Int. J. Mol. Sci. 2009, 10, 1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Li M., Ogiso M., Minoura N., Biomaterials 2003, 24, 357. [DOI] [PubMed] [Google Scholar]
- 43. Guo C., Li C., Kaplan D. L., Biomacromolecules 2020, 21, 1678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Chambre L., Parker R. N., Allardyce B. J., Valente F., Rajkhowa R., Dilley R. J., Wang X., Kaplan D. L., ACS Appl. Bio Mater. 2020, 3, 2466. [DOI] [PubMed] [Google Scholar]
- 45. Lu S., Tang X., Lu Q., Huang J., You X., Zhang F., Mater. Today Commun. 2021, 27, 102369. [Google Scholar]
- 46. Lu Q., Zhang B., Li M., Zuo B., Kaplan D. L., Huang Y., Zhu H., Biomacromolecules 2011, 12, 1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Wang Y., Rudym D. D., Walsh A., Abrahamsen L., Kim H. J., Kim H. S., Kirker‐Head C., Kaplan D. L., Biomaterials 2008, 29, 3415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Zheng H., Zuo B., J. Mater. Chem. B 2021, 9, 1238. [DOI] [PubMed] [Google Scholar]
- 49. Farokhi M., Aleemardani M., Solouk A., Mirzadeh H., Teuschl A. H., Redl H., Biomed. Mater. 2021, 16, 022004. [DOI] [PubMed] [Google Scholar]
- 50. Kim U. J., Park J., Li C., Jin H. J., Valluzzi R., Kaplan D. L., Biomacromolecules 2004, 5, 786. [DOI] [PubMed] [Google Scholar]
- 51. Yang C., Li S., Huang X., Chen X., Shan H., Chen X., Tao L., Zhang M., Oxid. Med. Cell. Longev. 2022, 2022, 2076680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Yin Z., Wu F., Xing T., Yadavalli V. K., Kundu S. C., Lu S., RSC Adv. 2017, 7, 24085. [Google Scholar]
- 53. Zhao Y., Zhu Z. S., Guan J., Wu S. J., Acta Biomater. 2021, 125, 57. [DOI] [PubMed] [Google Scholar]
- 54. Zhang Y., Zuo Y., Wen S., Hu Y., Min Y., Biomacromolecules 2018, 19, 1223. [DOI] [PubMed] [Google Scholar]
- 55. Kojic N., Pritchard E. M., Tao H., Brenckle M. A., Mondia J. P., Panilaitis B., Omenetto F., Kaplan D. L., Adv. Funct. Mater. 2012, 22, 3793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Cai B., Gu H., Wang F., Printon K., Gu Z., Hu X., Ultrason. Sonochem. 2021, 79, 105800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Nguyen A. T., Huang Q., Yang Z., Lin N., Xu G., Liu X., Small 2015, 11, 1039. [DOI] [PubMed] [Google Scholar]
- 58. Samal S. K., Kaplan D. L., Chiellini E., Macromol. Mater. Eng. 2013, 298, 1201. [Google Scholar]
- 59. Gorenkova N., Osama I., Seib F. P., Carswell H. V. O., ACS Biomater. Sci. Eng. 2018, 5, 859. [DOI] [PubMed] [Google Scholar]
- 60. Kaewprasit K., Kobayashi T., Damrongsakkul S., J. Appl. Polym. Sci. 2019, 137, 48731. [Google Scholar]
- 61. de Moraes M. A., Albrecht Mahl C. R., Ferreira Silva M., Beppu M. M., J. Appl. Polym. Sci. 2015, 132, 41802. [Google Scholar]
- 62. Chen H., Lin M., Lai Y., Chen B., J. Taiwan Inst. Chem. Eng. 2021, 129, 256. [Google Scholar]
- 63. Silva S. S., Oliveira N. M., Oliveira M. B., da Costa D. P. S., Naskar D., Mano J. F., Kundu S. C., Reis R. L., Acta Biomater. 2016, 32, 178. [DOI] [PubMed] [Google Scholar]
- 64. Garcia‐Fuentes M., Giger E., Meinel L., Merkle H. P., Biomaterials 2008, 29, 633. [DOI] [PubMed] [Google Scholar]
- 65. Floren M. L., Spilimbergo S., Motta A., Migliaresi C., Biomacromolecules 2012, 13, 2060. [DOI] [PubMed] [Google Scholar]
- 66. Elliott W. H., Bonani W., Maniglio D., Motta A., Tan W., Migliaresi C., ACS Appl. Mater. Interfaces 2015, 7, 12099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Lu Q., Bai S., Ding Z., Guo H., Shao Z., Zhu H., Kaplan D. L., Adv. Mater. Interfaces 2016, 3, 1500687. [Google Scholar]
- 68. Kojic N., Panzer M. J., Leisk G. G., Raja W. K., Kojic M., Kaplan D. L., Soft Matter 2012, 8, 6897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Hirlekar S., Ray D., Aswal V. K., Prabhune A., Nisal A., Ravindranathan S., Langmuir 2019, 35, 14870. [DOI] [PubMed] [Google Scholar]
- 70. Park J. H., Kim M. H., Jeong L., Cho D., Kwon O. H., Park W. H., J. Sol‐Gel Sci. Technol. 2014, 71, 364. [Google Scholar]
- 71. Li Z., Zheng Z., Yang Y., Fang G., Yao J., Shao Z., Chen X., ACS Sustain. Chem. Eng. 2016, 4, 1500. [Google Scholar]
- 72. Chirila T. V., Suzuki S., Papolla C., Biotechnol. Appl. Biochem. 2017, 64, 771. [DOI] [PubMed] [Google Scholar]
- 73. Raia N. R., Partlow B. P., McGill M., Kimmerling E. P., Ghezzi C. E., Kaplan D. L., Biomaterials 2017, 131, 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Zhou B., Wang P., Cui L., Yu Y., Deng C., Wang Q., Fan X., Appl. Biochem. Biotechnol. 2017, 182, 1548. [DOI] [PubMed] [Google Scholar]
- 75. Goczkowski M., Gobin M., Hindie M., Agniel R., Larreta‐Garde V., Mater. Sci. Eng. C 2019, 104, 109931. [DOI] [PubMed] [Google Scholar]
- 76. Johari N., Moroni L., Samadikuchaksaraei A., Eur. Polym. J. 2020, 134, 109842. [Google Scholar]
- 77. You R., Xu Y., Liu G., Liu Y., Li X., Li M., Polymer. Degrad. Stabil. 2014, 109, 226. [Google Scholar]
- 78. Vasconcelos A., Gomes A. C., Cavaco‐Paulo A., Acta Biomater. 2012, 8, 3049. [DOI] [PubMed] [Google Scholar]
- 79. Kanokpanont S., Damrongsakkul S., Ratanavaraporn J., Aramwit P., Int. J. Pharm. 2012, 436, 141. [DOI] [PubMed] [Google Scholar]
- 80. Tsukada M., Nagura M., Ishkawa H., Shiozaki H., J. Appl. Polym. Sci. 1991, 43, 643. [Google Scholar]
- 81. Niu H., Xiao J., Lou X., Guo L., Zhang Y., Yang R., Yang H., Wang S., Niu F., Front. Bioeng. Biotechnol. 2022, 10, 800830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Wang Y., Wang X., Shi J., Zhu R., Zhang J., Zhang Z., Ma D., Hou Y., Lin F., Yang J., Mizuno M., Sci. Rep. 2016, 6, 39477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Whittaker J. L., Choudhury N. R., Dutta N. K., Zannettino A., J. Mater. Chem. B 2014, 2, 6259. [DOI] [PubMed] [Google Scholar]
- 84. Whittaker J. L., Dutta N. K., Zannettino A., Choudhury N. R., J. Mater. Chem. B 2016, 4, 5519. [DOI] [PubMed] [Google Scholar]
- 85. Applegate M. B., Partlow B. P., Coburn J., Marelli B., Pirie C., Pineda R., Kaplan D. L., Omenetto F. G., Adv. Mater. 2016, 28, 2417. [DOI] [PubMed] [Google Scholar]
- 86. Kuang D., Jiang F., Wu F., Kaur K., Ghosh S., Kundu S. C., Lu S., Int. J. Biol. Macromol. 2019, 134, 838. [DOI] [PubMed] [Google Scholar]
- 87. Barroso I. A., Man K., Villapun V. M., Cox S. C., Ghag A. K., ACS Biomater. Sci. Eng. 2021, 7, 4779. [DOI] [PubMed] [Google Scholar]
- 88. Kim S. H., Yeon Y. K., Lee J. M., Chao J. R., Lee Y. J., Seo Y. B., Sultan M. T., Lee O. J., Lee J. S., Yoon S. I., Hong I. S., Khang G., Lee S. J., Yoo J. J., Park C. H., Nat. Commun. 2018, 9, 1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Kim S. H., Hong H., Ajiteru O., Sultan M. T., Lee Y. J., Lee J. S., Lee O. J., Lee H., Park H. S., Choi K. Y., Lee J. S., Ju H. W., Hong I. S., Park C. H., Nat. Protoc. 2021, 16, 5484. [DOI] [PubMed] [Google Scholar]
- 90. Kim S. H., Lee Y. J., Chao J. R., Kim D. Y., Sultan M. T., Lee H. J., Lee J. M., Lee J. S., Lee O. J., Hong H., Lee H., Ajiteru O., Suh Y. J., Choi H. S., Cho Y. J., Park C. H., NPG Asia Mater. 2020, 12, 46. [Google Scholar]
- 91. Kim M. H., Kim B. S., Lee J., Cho D., Kwon O. H., Park W. H., Biomater. Res. 2017, 21, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Kim M. H., Park W. H., Int. J. Nanomed. 2016, 11, 2967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Kim C. S., Yang Y. J., Bahn S. Y., Cha H. J., NPG Asia Mater. 2017, 9, e391. [Google Scholar]
- 94. Su D., Yao M., Liu J., Zhong Y., Chen X., Shao Z., ACS Appl. Mater. Interfaces 2017, 9, 17489. [DOI] [PubMed] [Google Scholar]
- 95. Xiao W., Qu X., Li J., Chen L., Tan Y., Li K., Li B., Liao X., Eur. Polymer J. 2019, 118, 382. [Google Scholar]
- 96. Harkin D. G., George K. A., Madden P. W., Schwab I. R., Hutmacher D. W., Chirila T. V., Biomaterials 2011, 32, 2445. [DOI] [PubMed] [Google Scholar]
- 97. Chouhan D., Lohe T. U., Samudrala P. K., Mandal B. B., Adv. Healthc. Mater. 2018, 7, 1801092. [DOI] [PubMed] [Google Scholar]
- 98. Jing J., Liang S., Yan Y., Tian X., Li X., ACS Biomater. Sci. Eng. 2019, 5, 4601. [DOI] [PubMed] [Google Scholar]
- 99. Yao Q., Lan Q., Jiang X., Du C., Zhai Y., Shen X., Xu H., Xiao J., Kou L., Zhao Y., Theranostics 2020, 10, 11719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Wang L., Chen Z., Yan Y., He C., Li X., Chem. Eng. J. 2021, 418, 129308. [Google Scholar]
- 101. Liu L., Ding Z., Yang Y., Zhang Z., Lu Q., Kaplan D. L., Biomater. Sci. 2021, 9, 5227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Zhang F., Yin C., Qi X., Guo C., Wu X., Macromol. Biosci. 2022, 22, 2100407. [DOI] [PubMed] [Google Scholar]
- 103. Melke J., Midha S., Ghosh S., Ito K., Hofmann S., Acta Biomater. 2016, 31, 1. [DOI] [PubMed] [Google Scholar]
- 104. Meinel L., Fajardo R., Hofmann S., Langer R., Chen J., Snyder B., Vunjak‐Novakovic G., Kaplan D., Bone 2005, 37, 688. [DOI] [PubMed] [Google Scholar]
- 105. Wang B., Yuan S., Xin W., Chen Y., Fu Q., Li L., Jiao Y., Int. J. Biol. Macromol. 2021, 192, 407. [DOI] [PubMed] [Google Scholar]
- 106. Zheng A., Cao L., Liu Y., Wu J., Zeng D., Hu L., Zhang X., Jiang X., Carbohydr. Polymer. 2018, 199, 244. [DOI] [PubMed] [Google Scholar]
- 107. Shen K., Duan A., Cheng J., Yuan T., Zhou J., Song H., Chen Z., Wan B., Liu J., Zhang X., Zhang Y., Xie R., Liu F., Fan W., Zuo Q., Acta Biomater. 2022, 143, 173. [DOI] [PubMed] [Google Scholar]
- 108. Cheng Y., Cheng G., Xie C., Yin C., Dong X., Li Z., Zhou X., Wang Q., Deng H., Li Z., Adv. Healthc. Mater. 2021, 10, 2001646. [DOI] [PubMed] [Google Scholar]
- 109. Jin Y., Kundu B., Cai Y., Kundu S. C., Yao J., Colloids Surf. B Biointerfaces 2015, 134, 339. [DOI] [PubMed] [Google Scholar]
- 110. Jiang L., Su D., Ding S., Zhang Q., Li Z., Chen F., Ding W., Zhang S., Dong J., Adv. Funct. Mater. 2019, 29, 1901314. [Google Scholar]
- 111. Zhang W., Wang X., Wang S., Zhao J., Xu L., Zhu C., Zeng D., Chen J., Zhang Z., Kaplan D. L., Jiang X., Biomaterials 2011, 32, 9415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Chao P. H., Yodmuang S., Wang X., Sun L., Kaplan D. L., Vunjak‐Novakovic G., J. Biomed. Mater. Res. B Appl. Biomater. 2010, 95, 84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Yodmuang S., McNamara S. L., Nover A. B., Mandal B. B., Agarwal M., Kelly T. A., Chao P. H., Hung C., Kaplan D. L., Vunjak‐Novakovic G., Acta Biomater. 2015, 11, 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Zhang W., Zhang Y., Li X., Cao Z., Mo Q., Sheng R., Ling C., Chi J., Yao Q., Chen J., Wang H., Mater. Today Bio 2022, 14, 100251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Wang X., Yang C., Yu Y., Zhao Y., Research 2022, 2022, 9794745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Li C., Cui W., Eng. Regen. 2021, 2, 195. [Google Scholar]
- 117. Chawla S., Midha S., Sharma A., Ghosh S., Adv. Healthc. Mater. 2018, 7, 1701204. [DOI] [PubMed] [Google Scholar]
- 118. Lee J. M., Sultan M. T., Kim S. H., Kumar V., Yeon Y. K., Lee O. J., Park C. H., Int. J. Mol. Sci. 2017, 18, 1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Li Q., Xu S., Feng Q., Dai Q., Yao L., Zhang Y., Gao H., Dong H., Chen D., Cao X., Bioact. Mater. 2021, 6, 3396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Zhang H., Zhang H., Wang H., Zhao Y., Chai R., Appl. Mater. Today 2022, 27, 101431. [Google Scholar]
- 121. Zhou L., Wang Z., Chen D., Lin J., Li W., Guo S., Wu R., Zhao X., Lin T., Chen G., Liu W., Mater. Des. 2022, 217, 110670. [Google Scholar]
- 122. Cai Y., Huang Q., Wang P., Ye K., Zhao Z., Chen H., Liu Z., Liu H., Wong H., Tamtaji M., Zhang K., Xu F., Jin G., Zeng L., Xie J., Du Y., Hu Z., Sun D., Qin J., Lu X., Luo Z., Adv. Healthc. Mater. 2022, 11, 2200755. [DOI] [PubMed] [Google Scholar]
- 123. Zhao Y., Liu J., Gao Y., Xu Z., Dai C., Li G., Sun C., Yang Y., Zhang K., J. Mater. Chem. B 2022, 10, 1582. [DOI] [PubMed] [Google Scholar]
- 124. Gu X., Chen X., Tang X., Zhou Z., Huang T., Yang Y., Ling J., Nanotechnol. Rev. 2021, 10, 10. [Google Scholar]
- 125. Tang X., Gu X., Huang T., Chen X., Zhou Z., Yang Y., Ling J., ACS Macro Lett. 2021, 10, 1501. [DOI] [PubMed] [Google Scholar]
- 126. Gao X., Cheng W., Zhang X., Zhou Z., Ding Z., Zhou X., Lu Q., Kaplan D. L., ACS Appl. Mater. Interfaces 2022, 14, 3701. [DOI] [PubMed] [Google Scholar]
- 127. Lin C., Chang J., Yung M., Huang W., Chen S., ACS Biomater. Sci. Eng. 2020, 6, 1144. [DOI] [PubMed] [Google Scholar]
- 128. Numata K., Kaplan D. L., Adv. Drug Deliver. Rev. 2010, 62, 1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129. Wu H., Liu S., Xiao L., Dong X., Lu Q., Kaplan D. L., ACS Appl. Mater. Interfaces 2016, 8, 17118. [DOI] [PubMed] [Google Scholar]
- 130. Wu J., Sahoo J. K., Li Y., Xu Q., Kaplan D. L., J. Control. Release 2022, 345, 176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131. Florczak A., Deptuch T., Kucharczyk K., Dams‐Kozlowska H., Cancers 2021, 13, 5389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Lovett M. L., Wang X., Yucel T., York L., Keirstead M., Haggerty L., Kaplan D. L., Eur. J. Pharm. Biopharm. 2015, 95, 271. [DOI] [PubMed] [Google Scholar]
- 133. Seib F. P., Pritchard E. M., Kaplan D. L., Adv. Funct. Mater. 2013, 23, 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134. Wu L., Tian K., Ding Z., Zhao T., Zhang X., Cheng W., Gao S., Lu Q., Kaplan D. L., Adv. Ther. 2022, 5, 2100231. [Google Scholar]
- 135. Ding Z., Zhou M., Zhou Z., Zhang W., Jiang X., Lu X., Zuo B., Lu Q., Kaplan D. L., ACS Biomater. Sci. Eng. 2019, 5, 4077. [DOI] [PubMed] [Google Scholar]
- 136. Kundu J., Poole‐Warren L. A., Martens P., Kundu S. C., Acta Biomater. 2012, 8, 1720. [DOI] [PubMed] [Google Scholar]
- 137. Yu R., Yang Y., He J., Li M., Guo B., Chem. Eng. J. 2021, 417, 128278. [Google Scholar]
- 138. Atterberry P. N., Roark T. J., Severt S. Y., Schiller M. L., Antos J. M., Murphy A. R., Biomacromolecules 2015, 16, 1582. [DOI] [PubMed] [Google Scholar]
- 139. Gangrade A., Mandal B. B., ACS Biomater. Sci. Eng. 2019, 5, 2365. [DOI] [PubMed] [Google Scholar]
- 140. Mandal B. B., Kapoor S., Kundu S. C., Biomaterials 2009, 30, 2826. [DOI] [PubMed] [Google Scholar]
- 141. Wu P., Liu Q., Wang Q., Qian H., Yu L., Liu B., Li R., Int. J. Nanomed. 2018, 13, 5405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142. Akrami‐Hasan‐Kohal M., Eskandari M., Solouk A., Colloids Surf. B Biointerfaces 2021, 205, 111892. [DOI] [PubMed] [Google Scholar]
- 143. Zhang X., Wang Y., Chi J., Zhao Y., Research 2020, 2020, 7462915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. Zhang X., Chen G., Yu Y., Sun L., Zhao Y., Research 2020, 2020, 3672120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145. Zhang X., Chen G., Cai L., Fan L., Zhao Y., Research 2022, 2022, 9797482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146. Chen S., Matsumoto H., Moro‐Oka Y., Tanaka M., Miyahara Y., Suganami T., Matsumoto A., ACS Biomater. Sci. Eng. 2019, 5, 5781. [DOI] [PubMed] [Google Scholar]
- 147. Zhang H., Liu Y., Chen G., Wang H., Chen C., Li M., Lu P., Zhao Y., Sci. Bull. 2020, 65, 380. [DOI] [PubMed] [Google Scholar]
- 148. Zhang H., Liu Y., Chen C., Cui W., Zhang C., Ye F., Zhao Y., Appl. Mater. Today 2020, 19, 100540. [Google Scholar]
- 149. Zhang H., Zhang Z., Zhang H., Chen C., Zhang D., Zhao Y., ACS Appl. Mater. Interfaces 2021, 13, 18413. [DOI] [PubMed] [Google Scholar]
- 150. Guo J., Yu Y., Zhang D., Zhang H., Zhao Y., Research 2021, 2021, 7065907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151. Yu Y., Guo J., Sun L., Zhang X., Zhao Y., Research 2019, 2019, 6906275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152. Sun X., He S., Yao M., Wu X., Zhang H., Yao F., Li J., J. Mater. Chem. C 2021, 9, 1880. [Google Scholar]
- 153. Chen F., Lu S., Zhu L., Tang Z., Wang Q., Qin G., Yang J., Sun G., Zhang Q., Chen Q., J. Mater. Chem. B 2019, 7, 1708. [DOI] [PubMed] [Google Scholar]
- 154. Liu X., Liu J., Wang J., Wang T., Jiang Y., Hu J., Liu Z., Chen X., Yu J., ACS Appl. Mater. Interfaces 2020, 12, 5601. [DOI] [PubMed] [Google Scholar]
- 155. Li S., Liu G., Wen H., Liu G., Wang H., Ye M., Yang Y., Guo W., Liu Y., Adv. Funct. Mater. 2022, 32, 2111747. [Google Scholar]
- 156. Zheng H., Chen M., Sun Y., Zuo B., Chem. Eng. J. 2022, 446, 136931. [Google Scholar]
- 157. Zhou B., Li Y., Chen Y., Gao C., Li J., Bai Z., Guo J., Chem. Eng. J. 2022, 446, 137405. [Google Scholar]
- 158. Chu T., Wang H., Qiu Y., Luo H., He B., Wu B., Gao B., Analyst 2021, 146, 1552. [DOI] [PubMed] [Google Scholar]
- 159. Wang J., Zhang N., Tan Y., Fu F., Liu G., Fang Y., Zhang X., Liu M., Cheng Y., Yu J., ACS Appl. Mater. Interfaces 2022, 14, 21945. [DOI] [PubMed] [Google Scholar]
- 160. Zhao L., Zhao J., Zhang F., Xu Z., Chen F., Shi Y., Hou C., Huang Y., Lin C., Yu R., Guo W., Adv. Healthc. Mater. 2021, 10, 2002083. [DOI] [PubMed] [Google Scholar]
- 161. Zheng H., Lin N., He Y., Zuo B., ACS Appl. Mater. Interfaces 2021, 13, 40013. [DOI] [PubMed] [Google Scholar]
- 162. He F., You X., Gong H., Yang Y., Bai T., Wang W., Guo W., Liu X., Ye M., ACS Appl. Mater. Interfaces 2020, 12, 6442. [DOI] [PubMed] [Google Scholar]
- 163. Zhang S., Zhou Z., Zhong J., Shi Z., Mao Y., Tao T. H., Adv. Sci. 2020, 7, 1903802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164. Zhang H., Guo J., Wang Y., Sun L., Zhao Y., Adv. Sci. 2021, 8, 2102156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165. Chen Q., Tang H., Liu J., Wang R., Sun J., Yao J., Shao Z., Chen X., Chem. Eng. J. 2021, 422, 130091. [Google Scholar]
- 166. Wang C., Zhu M., Yu H., Abdalkarim S. Y. H., Ouyang Z., Zhu J., Yao J., ACS Appl. Mater. Interfaces 2021, 13, 33371. [DOI] [PubMed] [Google Scholar]
- 167. Seo J. W., Kim H., Kim K., Choi S. Q., Lee H. J., Adv. Funct. Mater. 2018, 28, 1800802. [Google Scholar]
- 168. Wahab A., Gogurla N., Park J. Y., Kim S., Adv. Mater. Technol. 2022, 7, 2101271. [Google Scholar]